
Dr. Manisha Rajpal Singh is an experienced Gynaecologist and Reproductive Medicine specialist serving as Additional Director of Reproductive Medicine at Fortis Hospital, Bannerghatta Road, Bengaluru. With over 30 years of clinical experience, she specialises in reproductive medicine, infertility management and advanced gynaecological surgery.
She completed her MBBS, DGO, DNB and MD in Obstetrics and Gynaecology, followed by MRCOG from the United Kingdom. She also holds a Doctorate in Reproductive Medicine from the University of Leeds, UK, and has received specialised training and accreditation in reproductive medicine and surgery through the Royal College of Obstetricians and Gynaecologists.
Her clinical expertise includes assisted conception, IVF, ICSI, IUI and advanced reproductive medicine. She also specialises in minimal access gynaecological surgery, including laparoscopic and hysteroscopic procedures, treatment of endometriosis, fibroids, ovarian cysts and other reproductive health conditions. She is also trained in robotic surgery.
Before returning to India, Dr. Singh worked as a Consultant Gynaecologist and Subspecialist in Reproductive Medicine and Surgery at Saint Mary's University Teaching Hospital and Central Manchester University Hospitals NHS Foundation Trust in the United Kingdom. She has also contributed to professional education as a recognised trainer and assessor in reproductive medicine and minimally invasive surgery.
Decades of expertise, proven results, and compassionate care — here is why patients from 50+ countries trust Dr Manisha Singh for IVF & Fertility treatment in India.
Over 20 years of dedicated clinical experience with 5,000+ procedures. One of the most trusted names in IVF & Fertility in India.
Dr Manisha Singh regularly treats patients from Africa, the Middle East, Central Asia, and Europe. Dedicated international patient support team available 24/7.
Practices at an internationally accredited hospital, ensuring patient safety standards that match the best hospitals in the USA and Europe.
World-class treatment at a fraction of USA, UK, or Australian prices. Transparent cost estimates provided before you travel.
Dr Manisha Singh holds postgraduate qualifications from premier Indian institutions and has advanced fellowship training in IVF & Fertility.
Every case is personally reviewed. Treatment plans are tailored, transparent, and discussed in detail before you make any decisions or travel arrangements.
In-vitro fertilisation and intracytoplasmic sperm injection with advanced laboratory techniques and high success rates.
Microsurgical reanastomosis of fallopian tubes with high pregnancy success rates.
Intrauterine insemination and monitored ovulation induction for unexplained and mild male factor infertility.
Social and medical fertility preservation — egg, sperm, and embryo freezing using vitrification technology.
Myomectomy, endometriosis excision, ovarian cystectomy, and adhesiolysis to improve fertility.
PGT-A and PGT-M for chromosomal screening and monogenic disease testing before embryo transfer.
Evaluation and treatment of women with two or more consecutive pregnancy losses.
Semen analysis, DNA fragmentation testing, and surgical sperm retrieval in collaboration with urologists.
Laparoscopic diagnosis and surgical management of endometriosis affecting fertility.
In-vitro fertilisation and intracytoplasmic sperm injection with advanced laboratory techniques and blastocyst culture.
Microsurgical reanastomosis of fallopian tubes offering a permanent pathway to natural conception.
Intrauterine insemination with monitored stimulation for couples with unexplained or mild infertility.
Operative laparoscopy to correct structural causes of infertility including endometriosis and fibroids.
Vitrification-based egg and embryo freezing for social and medical fertility preservation.
Send your medical reports and get a personalised treatment plan. The team reviews cases from 50+ countries and responds within 24 hours.
Our team responds within 24 hours
Share your reports and receive a personalised treatment recommendation within 48 hours — at no cost.